Phenergan And Zofran: Safe During Pregnancy?

Morning sickness is a common problem during pregnancy, and medications like Phenergan and Zofran are often considered to help alleviate symptoms. Phenergan, or promethazine, is a medication used to treat nausea, vomiting, motion sickness, and allergies. Zofran, or ondansetron, is also used to treat nausea and vomiting, typically associated with chemotherapy or surgery. While both drugs are used to treat similar symptoms, there are questions about their safety during pregnancy, and it is important to understand the potential risks and benefits before making any decisions about medication use during pregnancy.

Phenergan is safe to take during early pregnancy

Nausea and vomiting are common symptoms during pregnancy, with upwards of 50-75% of women experiencing these symptoms, particularly during the first 10 weeks. Fortunately, Phenergan (promethazine) can be safely taken during pregnancy, even in early pregnancy, to alleviate these symptoms.

Phenergan is a first-generation (sedating) phenothiazine antihistamine used to treat nausea and vomiting, allergies, and for sedation. It is also used to treat motion sickness and vertigo. While the main side effect of Phenergan is fatigue, most pregnant people prefer feeling tired over experiencing nausea and vomiting. For those who are too nauseous to take a pill, Phenergan is also available in a rectal suppository form.

Studies, including two small studies on fetal exposure to promethazine through maternal overdose, do not suggest an association between in utero promethazine exposure and increased risks of congenital malformation, preterm delivery, low birth weight, or adverse neurodevelopmental outcomes. One small study did not report an increased chance of miscarriage in people taking promethazine. However, it is important to note that using Phenergan late in pregnancy might increase the risk of slowed breathing (respiratory depression) in newborns. Therefore, it is recommended to consult with a healthcare provider before taking Phenergan or any other medication during pregnancy.

Phenergan is available in a rectal suppository form for those who struggle to keep pills down

Phenergan, or Promethazine, is available in a 50mg rectal suppository form for those who struggle to keep pills down. It is used to treat nausea and vomiting related to certain conditions, such as motion sickness, or before/after surgery, as well as to treat allergic symptoms such as rashes, itching, and a runny nose.

The suppository is for rectal use only and should be administered 2 to 4 times daily as directed by a doctor. It is important to remain lying down for a few minutes after using this medication and to avoid having a bowel movement for an hour or longer so that the drug will be properly absorbed.

Phenergan is also available in tablet form, but for those who struggle to keep pills down, the suppository form may be a better option. It is important to note that Phenergan should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.

Zofran, on the other hand, is the trade name for ondansetron, a drug that blocks the action of serotonin, which can lead to nausea and vomiting. It is often prescribed off-label to reduce nausea and vomiting during pregnancy, especially in cases of severe morning sickness or hyperemesis gravidarum.

While Zofran is considered relatively safe, there are some reports of a slightly increased risk of cleft lip and palate, as well as heart defects in babies exposed to the drug during the first trimester. As such, it is important to discuss the risks and benefits of taking Zofran during pregnancy with your doctor.

Zofran is not approved by the FDA to treat morning sickness

While Zofran is a popular medication for morning sickness during pregnancy, it is not approved by the Food and Drug Administration (FDA) for this use. It is, however, approved by the FDA for treating nausea related to chemotherapy.

Zofran is the trade name for ondansetron, a drug that blocks the action of serotonin, which can lead to nausea and vomiting. It was originally used to treat nausea associated with chemotherapy, radiation, or surgery, and it is still approved by the FDA for this purpose.

Despite not being FDA-approved for treating morning sickness, Zofran has become a frequently prescribed drug for reducing nausea and vomiting in pregnancy. According to one source, about one in four pregnant women are prescribed Zofran for morning sickness.

The lack of FDA approval for this use is due to some studies suggesting a potential link between Zofran and a slightly increased risk of certain birth defects, such as cleft palate and heart defects. However, the evidence is inconclusive, and other studies have found no increased risk.

The consensus among experts is that taking Zofran during pregnancy is generally safe, and it is often prescribed when natural remedies and other medications have not been effective in managing morning sickness.

Zofran may increase the risk of cleft palate and heart defects in babies

Zofran, or Ondansetron, is a drug that blocks the effects of serotonin, a hormone and neurotransmitter that is believed to help manage your appetite, digestion, mood, social behaviour, sleep, and other functions. It is primarily used to treat nausea and vomiting caused by cancer treatments, but it has also become a frequently prescribed drug to reduce nausea and vomiting in pregnancy.

While Zofran is approved by the Food and Drug Administration (FDA) for use to fight off nausea related to chemotherapy, it is not currently approved by the FDA for morning sickness. However, most studies show that ondansetron is safe to use during the first trimester when most women experience morning sickness.

That being said, a meta-analysis of eight studies suggested that exposure to ondansetron in the first trimester could cause a very small increase in the risk of heart defects and orofacial malformations, such as cleft palate, in babies. The reported absolute increase in risk was 0.03% for cleft palate and 0.03% for heart defects. The CDC and the FDA, however, found that taking ondansetron in early pregnancy did not seem to be linked to the likelihood of having a baby with a health problem.

The medical community recognises the risk as small but existent, and some physicians are starting to prescribe Zofran less and less.

Zofran may cause maternal heart issues

Zofran is a drug that blocks the effects of serotonin, a hormone and neurotransmitter that is believed to help manage your appetite, digestion, mood, social behaviour, sleep, and other functions. It is primarily used to treat nausea and vomiting in people with cancer caused by chemotherapy, radiation, or surgery.

In September 2011, the FDA gave a warning that taking Zofran might increase the risk of maternal heart issues, namely QT prolongation and torsade de pointes. Both of these conditions cause irregular heartbeats, and torsade de pointes can even have fatal outcomes.

The warning was based on research that suggested there may be a very small increase in cardiac abnormalities and cleft palates in babies exposed to Zofran early in pregnancy. However, it was acknowledged that the increase could be affected by other factors and that the overall risk of birth defects associated with Zofran exposure appears to be low.

The conflicting findings of the studies highlight the importance of discussing treatment options with a doctor to figure out the right choice for the individual. While Zofran is generally considered safe, there are alternative treatments available that may be preferred in certain cases.

Frequently asked questions